Implications of inhomogeneous distribution of IKS and IKr channels in ventricle with respect to effects of class III agents and beta-agonists.
van Ginneken
A C
AC
Veldkamp
M W
MW
D000200:Action Potentials / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D006325:Heart Atria; D006339:Heart Rate / Q000187:drug effects*; D006352:Heart Ventricles; D009206:Myocardium / Q000378:metabolism*; D015221:Potassium Channels / Q000187:drug effects*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
D000318:Adrenergic beta-Agonists; D000889:Anti-Arrhythmia Agents; D015221:Potassium Channels; D000254:Sodium-Potassium-Exchanging ATPase